Mutation detail:
| Mutation site | R151I |
| Virus | Varicella-Zoster virus |
Mutation level  |
Amino acid level |
| Gene/protein/region type | ORF11 |
| Gene ID | 1487654 |
| Country | - |
| Mutation type |
nonsynonymous mutation |
| Genotype/subtype/clade | - |
| Sample |
cell line |
| Variants | - |
| Viral reference sequence | NC_001348.1 |
| Drug/antibody/vaccine | - |
| Transmissibility |
- |
| Transmission mechanism | - |
| Pathogenicity |
- |
| Pathogenicity mechanism | - |
| Immune escape mutation | - |
| Immune escape mechanism | - |
| RT-PCR primers probes | - |
Protein detail:
| Protein name | Tegument Protein VP13/14 |
| Uniprot protein ID | - |
| Protein length | 819 amino acids |
| Protein description | Tegument protein; required for normal levels of IE4, IE62, IE63 and gE; RNA-binding domain (amino acids 1-22); binding to ORF9 required for efficient virion assembly. |
Literature information:
| Pubmed ID | 29242077 |
| Clinical information | No |
| Disease | - |
| Published year | 2017 |
| Journal | Virus Passaged in Cell Culture |
| Title | Vaccine-Type Mutations Identified in Varicella Zoster Virus Passaged in Cell Culture |
| Author | Seok Cheon Kim1 , Youn Hee Won1 , Ji Seon Park1 , Jeong Seon Jeon1 , Jin Hyun Ahn |
| Evidence | Table3 |